There also seems to be a shift in the science and medicine of life extension.
Billionaire’s like Jim Mellon, Craig Venter, Peter Thiel and others are believing in radical life extension and investing in companies to develop that capability.
Jim Mellon and Al Chalabi’s wrote a new book Juvenescence: Investing in the Age of Longevity. It is the first time that a group of financially influential individuals have come out and, at length and in detail, outlined why exactly they support the cause of rejuvenation research and why they think it has a good chance of success in the near future.
Jim Mellon’s investment philosophy, which has led him to be recognised as one of the most successful investors of his generation, is underpinned by his ability to identify so-called “money-fountains” – market trends which will lead to step changes and the resulting investment opportunities. “This is the biggest money fountain idea that Al and I have ever seen. The longevity business has quickly moved from wacky land to serious science, and within just a couple of decades we expect average human life expectancy in the developed world to rise to around 110.”
Space launch has shown it can be more difficult, time consuming and costly to pursue less ambitious goals than it is to pursue radically transformative goals.
NASA, Boeing and others had more money and resources than Elon and Spacex and pursued more timid projects. They spend far more money and more time and achieved less.